Development and validation of an HPLC coupled with tandem mass spectrometry method for the determination of HSK7653, a novel super long‐acting dipeptidyl peptidase‐4 inhibitor, in human plasma and urine and its application to a pharmacokinetic study

• Published in: Biomedical chromatography Vol. 37; no. 5; pp. e5607 - n/a
• Main Authors: Liu, Yang, Yan, Shuai, Liu, Jie, Liu, Hongzhong, Song, Ling, Yao, Xueting, Jiang, Ji, Li, Fangqiong, Du, Ke, Liu, Dongyang, Hu, Pei
• Format: Journal Article
• Language: English
• Published: England 01.05.2023
• Subjects: Chromatography, High Pressure Liquid - methods; Diabetes Mellitus, Type 2 - drug therapy; Dipeptidyl-Peptidase IV Inhibitors; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; first‐in‐human study; HPLC–MS/MS; HSK7653; human plasma and urine; Humans; Hypoglycemic Agents; method validation; pharmacokinetics; Reproducibility of Results; Tandem Mass Spectrometry - methods; HSK7653; method validation; pharmacokinetics; human plasma and urine; HPLC-MS/MS; first-in-human study
• ISSN: 0269-3879; 1099-0801
• DOI: 10.1002/bmc.5607

HSK7653 is a novel super long‐acting dipeptidyl peptidase‐4 inhibitor, which is promising for the treatment of type 2 diabetes mellitus with the twice‐monthly dosing regimen. In this article, a robust and sensitive HPLC coupled with tandem mass spectrometry method for determining the concentration of HSK7653 in human plasma and urine was developed and validated for the first time. Plasma and urine samples were prepared by protein precipitation. After that, the extracts were analyzed using an LC‐20A HPLC system coupled with API 4000 tandem MS equipped with an electrospray ionization source in positive mode. Separation was obtained using an XBridge Phenyl column (2.1 × 50 mm, 3.5 μm) with a gradient elution of acetonitrile and water containing 0.1% formic acid and 5% acetonitrile at room temperature. This bioanalysis method has been fully validated and the results showed good sensitivity and specificity. In brief, the standard curves were linear over the concentration range of 2.00–2000 ng/ml for plasma and 20.0–20,000 ng/ml for urine, respectively. In addition, the precisions of inter‐ and intra‐run of HSK7653 were less than 12.7% and the accuracies were −3.3% to 6.3% for both plasma and urine. Finally, this method was successfully applied to explore the pharmacokinetic characteristics of HSK7653 in Chinese healthy volunteers in a first‐in‐human study.